Prognostic relevance of immune-related adverse events in lung cancer patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Article in Translational Lung Cancer Research (July 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis
Article in Frontiers in Oncology (June 2024)
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Article in Nature Communications (March 2024)